Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation

被引:53
作者
Morelon, E [1 ]
Mamzer-Bruneel, MF [1 ]
Peraldi, MN [1 ]
Kreis, H [1 ]
机构
[1] Hop Necker Enfants Malad, Transplantat Serv, F-75743 Paris 15, France
关键词
immunosuppressive drugs; rapamycin; renal transplantation; sirolimus;
D O I
10.1093/ndt/16.1.18
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:18 / 20
页数:3
相关论文
共 19 条
[1]   Immunopharmacology of rapamycin [J].
Abraham, RT ;
Wiederrecht, GJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :483-510
[2]   EFFECTS OF RAPAMYCIN ON RENAL HEMODYNAMICS, WATER AND SODIUM-EXCRETION, AND PLASMA-LEVELS OF ANGIOTENSIN-II, ALDOSTERONE, ATRIAL, NATRIURETIC PEPTIDE, AND VASOPRESSIN IN PIGS [J].
GOLBAEKDAL, K ;
NIELSEN, CB ;
DJURHUUS, JC ;
PEDERSEN, EB .
TRANSPLANTATION, 1994, 58 (11) :1153-1157
[3]   TREATMENT WITH RAPAMYCIN AND MYCOPHENOLIC-ACID REDUCES ARTERIAL INTIMAL THICKENING PRODUCED BY MECHANICAL INJURY AND ALLOWS ENDOTHELIAL REPLACEMENT [J].
GREGORY, CR ;
HUANG, XF ;
PRATT, RE ;
DZAU, VJ ;
SHORTHOUSE, R ;
BILLINGHAM, ME ;
MORRIS, RE .
TRANSPLANTATION, 1995, 59 (05) :655-661
[4]   Sirolimus (rapamycin)-based therapy in human renal transplantation -: Similar efficacy and different toxicity compared with cyclosporine [J].
Groth, CG ;
Bäckman, L ;
Morales, JM ;
Calne, R ;
Kreis, H ;
Lang, P ;
Touraine, JL ;
Claesson, K ;
Campistol, JM ;
Durand, D ;
Wramner, L ;
Brattström, C ;
Charpentier, B .
TRANSPLANTATION, 1999, 67 (07) :1036-1042
[5]   SYNERGISTIC INTERACTIONS OF CYCLOSPORINE AND RAPAMYCIN TO INHIBIT IMMUNE PERFORMANCES OF NORMAL HUMAN PERIPHERAL-BLOOD LYMPHOCYTES INVITRO [J].
KAHAN, BD ;
GIBBONS, S ;
TEJPAL, N ;
STEPKOWSKI, SM ;
CHOU, TC .
TRANSPLANTATION, 1991, 51 (01) :232-239
[6]   PRODUCTION OF SYNERGISTIC BUT NONIDENTICAL MECHANISMS OF IMMUNOSUPPRESSION BY RAPAMYCIN AND CYCLOSPORINE [J].
KIMBALL, PM ;
KERMAN, RH ;
KAHAN, BD .
TRANSPLANTATION, 1991, 51 (02) :486-490
[7]   Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients [J].
Kreis, H ;
Cisterne, JM ;
Land, W ;
Wramner, L ;
Squifflet, JP ;
Abramowicz, D ;
Campistol, JM ;
Morales, JM ;
Grinyo, JM ;
Mourad, G ;
Berthoux, FC ;
Brattström, C ;
Lebranchu, Y ;
Vialtel, P .
TRANSPLANTATION, 2000, 69 (07) :1252-1260
[8]   Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance [J].
Li, YS ;
Li, XC ;
Zheng, XX ;
Wells, AD ;
Turka, LA ;
Strom, TB .
NATURE MEDICINE, 1999, 5 (11) :1298-1302
[9]  
Mahalati K, 2000, TRANSPLANTATION, V69, P1531
[10]   The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo:: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders [J].
Majewski, M ;
Korecka, M ;
Kossev, P ;
Li, SY ;
Goldman, J ;
Moore, J ;
Silberstein, LE ;
Nowell, PC ;
Schuler, W ;
Shaw, LM ;
Wasik, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :4285-4290